Browse study websites

Discover. Prevent. Cure.

Menu Fundraise Donate

    Recommended pages

      Do you mean

        891-900 of 1964 results for 'Council'

        Refine search

        Research

        Examining ERBB2 as a candidate gene for susceptibility to leprosy (Hansen's disease) in Brazil

        This study examines whether polymorphisms in the ERBB2 gene were associated with leprosy in primary and replication cohorts from northeastern Brazil. ...

        Research

        Re-evaluation of link between interpregnancy interval and adverse birth outcomes: Retrospective cohort study matching two intervals per mother

        This study questions the causal effect of short interpregnancy intervals on adverse birth outcomes and points to the possibility of unmeasured or... ...

        Research

        Genetics of Otitis Media

        Sarra Jenefer Jamieson Blackwell SE JM BSc (Hons) MSc PhD BSc with First Class Honours, PhD, DSc, FMedSci, FAA Senior Research Fellow Head, Genetics ...

        Research

        Kids are not small adults, Identifying age-dependent drug targets in paediatric oncology

        Omar Merridee Sébastien Laurence Rishi Sury Terrance Timo Raelene W. Joost Elaskalani Wouters Malinge Cheung Kotecha Johns Lassmann Endersby ...

        Research

        Public Health Approach to Child Abuse and Neglect: Antecedents and Outcomes

        Melissa Fiona Helen Rebecca Peter O'Donnell Stanley Leonard Glauert Jacoby M FJ HM RA PJ BPsych (Hons), MPsych, GradDip Ed, PhD FAA FASSA MSc MD ...

        Spectrum

        $10m+ $1m - $9,999,999 $500k - $999,999 $100k - $499,999 $25k - $99,999 $10k - $24,999 $1 - $9,999 Ultraviolet The Australian Government BHP Bill & ...

        Research

        COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children’s Haematology/Oncology Group consensus statement

        The Australian Technical Advisory Group on Immunisation and New Zealand Ministry of Health recommend all children aged ≥ 5 years receive either of the two mRNA COVID-19 vaccines: Comirnaty (Pfizer), available in both Australia and New Zealand, or Spikevax (Moderna), available in Australia only. Both vaccines are efficacious and safe in the general population, including children. Children and adolescents undergoing treatment for cancer and immunosuppressive therapy for non-malignant haematological conditions are particularly vulnerable, with an increased risk of severe or fatal COVID-19. ...

        Research

        Ngulluk Koolunga Ngulluk Koort (Our Children, Our Heart) Program

        Brad Carol Glenn Carrington Steve Farrant Michie Pearson Shepherd Zubrick Related Projects Elder Researchers Contact BM C G CCJ SR If you would like ...

        Research

        Modelling the seasonal epidemics of respiratory syncytial virus in young children

        This paper describes a mathematical model used to predict when an epidemic of respiratory syncytial virus (RSV) will occur so that preventive measures, such... ...

        Research

        Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer

        The trivalent inactivated influenza vaccine is safe, immunogenic, provides clinical protection and should be administered annually to immunosuppressed children receiving treatment for cancer ...

        Page 90 of 197